您的位置: 首页 > 农业专利 > 详情页

MSI-specific frameshift peptides (FSP) for prevention and treatment of cancer
专利权人:
Ruprecht-Karls-Universitat Heidelberg
发明人:
Matthias Kloor,Miriam Reuschenbach,Magnus von Knebel-Doeberitz
申请号:
US14926329
公开号:
US09770499B2
申请日:
2015.10.29
申请国别(地区):
US
年份:
2017
代理人:
摘要:
Described is a vaccine for prevention and treatment of cancer characterized by microsatellite instability (MSI). The vaccine contains an MSI-specific frameshift peptide (FSP) generating humoral and cellular responses against tumor cells or a nucleic acid encoding said FSP. The vaccine of the present invention is particularly useful for the prevention/treatment of colorectal cancer, endometrial cancer, gastric cancer or small bowel cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充